Cargando…
A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice
Enterotoxigenic Escherichia coli (ETEC) is the primary etiologic agent of traveler’s diarrhea and a major cause of diarrheal disease and death worldwide, especially in infants and young children. Despite significant efforts over the past several decades, an affordable vaccine that appreciably decrea...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018396/ https://www.ncbi.nlm.nih.gov/pubmed/36936989 http://dx.doi.org/10.3389/fmolb.2023.1085887 |
_version_ | 1784907801956450304 |
---|---|
author | Williams, Asher J. Warfel, Katherine F. Desai, Primit Li, Jie Lee, Jen-Jie Wong, Derek A. Nguyen, Phuong M. Qin, Yufan Sobol, Sarah E. Jewett, Michael C. Chang, Yung-Fu DeLisa, Matthew P. |
author_facet | Williams, Asher J. Warfel, Katherine F. Desai, Primit Li, Jie Lee, Jen-Jie Wong, Derek A. Nguyen, Phuong M. Qin, Yufan Sobol, Sarah E. Jewett, Michael C. Chang, Yung-Fu DeLisa, Matthew P. |
author_sort | Williams, Asher J. |
collection | PubMed |
description | Enterotoxigenic Escherichia coli (ETEC) is the primary etiologic agent of traveler’s diarrhea and a major cause of diarrheal disease and death worldwide, especially in infants and young children. Despite significant efforts over the past several decades, an affordable vaccine that appreciably decreases mortality and morbidity associated with ETEC infection among children under the age of 5 years remains an unmet aspirational goal. Here, we describe robust, cost-effective biosynthetic routes that leverage glycoengineered strains of non-pathogenic E. coli or their cell-free extracts for producing conjugate vaccine candidates against two of the most prevalent O serogroups of ETEC, O148 and O78. Specifically, we demonstrate site-specific installation of O-antigen polysaccharides (O-PS) corresponding to these serogroups onto licensed carrier proteins using the oligosaccharyltransferase PglB from Campylobacter jejuni. The resulting conjugates stimulate strong O-PS-specific humoral responses in mice and elicit IgG antibodies that possess bactericidal activity against the cognate pathogens. We also show that one of the prototype conjugates decorated with serogroup O148 O-PS reduces ETEC colonization in mice, providing evidence of vaccine-induced mucosal protection. We anticipate that our bacterial cell-based and cell-free platforms will enable creation of multivalent formulations with the potential for broad ETEC serogroup protection and increased access through low-cost biomanufacturing. |
format | Online Article Text |
id | pubmed-10018396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100183962023-03-17 A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice Williams, Asher J. Warfel, Katherine F. Desai, Primit Li, Jie Lee, Jen-Jie Wong, Derek A. Nguyen, Phuong M. Qin, Yufan Sobol, Sarah E. Jewett, Michael C. Chang, Yung-Fu DeLisa, Matthew P. Front Mol Biosci Molecular Biosciences Enterotoxigenic Escherichia coli (ETEC) is the primary etiologic agent of traveler’s diarrhea and a major cause of diarrheal disease and death worldwide, especially in infants and young children. Despite significant efforts over the past several decades, an affordable vaccine that appreciably decreases mortality and morbidity associated with ETEC infection among children under the age of 5 years remains an unmet aspirational goal. Here, we describe robust, cost-effective biosynthetic routes that leverage glycoengineered strains of non-pathogenic E. coli or their cell-free extracts for producing conjugate vaccine candidates against two of the most prevalent O serogroups of ETEC, O148 and O78. Specifically, we demonstrate site-specific installation of O-antigen polysaccharides (O-PS) corresponding to these serogroups onto licensed carrier proteins using the oligosaccharyltransferase PglB from Campylobacter jejuni. The resulting conjugates stimulate strong O-PS-specific humoral responses in mice and elicit IgG antibodies that possess bactericidal activity against the cognate pathogens. We also show that one of the prototype conjugates decorated with serogroup O148 O-PS reduces ETEC colonization in mice, providing evidence of vaccine-induced mucosal protection. We anticipate that our bacterial cell-based and cell-free platforms will enable creation of multivalent formulations with the potential for broad ETEC serogroup protection and increased access through low-cost biomanufacturing. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10018396/ /pubmed/36936989 http://dx.doi.org/10.3389/fmolb.2023.1085887 Text en Copyright © 2023 Williams, Warfel, Desai, Li, Lee, Wong, Nguyen, Qin, Sobol, Jewett, Chang and DeLisa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Williams, Asher J. Warfel, Katherine F. Desai, Primit Li, Jie Lee, Jen-Jie Wong, Derek A. Nguyen, Phuong M. Qin, Yufan Sobol, Sarah E. Jewett, Michael C. Chang, Yung-Fu DeLisa, Matthew P. A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice |
title | A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice |
title_full | A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice |
title_fullStr | A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice |
title_full_unstemmed | A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice |
title_short | A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in mice |
title_sort | low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic escherichia coli infections in mice |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018396/ https://www.ncbi.nlm.nih.gov/pubmed/36936989 http://dx.doi.org/10.3389/fmolb.2023.1085887 |
work_keys_str_mv | AT williamsasherj alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT warfelkatherinef alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT desaiprimit alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT lijie alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT leejenjie alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT wongdereka alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT nguyenphuongm alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT qinyufan alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT sobolsarahe alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT jewettmichaelc alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT changyungfu alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT delisamatthewp alowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT williamsasherj lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT warfelkatherinef lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT desaiprimit lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT lijie lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT leejenjie lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT wongdereka lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT nguyenphuongm lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT qinyufan lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT sobolsarahe lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT jewettmichaelc lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT changyungfu lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice AT delisamatthewp lowcostrecombinantglycoconjugatevaccineconfersimmunogenicityandprotectionagainstenterotoxigenicescherichiacoliinfectionsinmice |